University of Delaware
Newark, Delaware, 19716, United States
NCT Number: NCT02881515
Excess dietary salt increases the risk for cardiovascular events, even in people that are not hypertensive. There is some evidence that excess dietary salt exaggerates blood pressure and sympathetic nervous system responses to various perturbations and increases blood pressure variability. This proposal will examine the effects of low, medium, and high salt diets on cardiovascular reactivity and blood pressure variability.
Looking for future studies?
Notify Me21 year–75 year
All sexes
Interventional
Not applicable
Newark, Delaware, 19716, United States
Excess dietary salt causes target organ damage and increases the risk for adverse cardiovascular (CV) events independent of blood pressure (BP). Recent data in salt-resistant, normotensive rodents suggest that high dietary salt enhances the excitability or gain of sympathetic circuits, exaggerates sympathetic and CV responses to various stimuli, and increases BP variability (BPV). There are limited data regarding the impact of dietary salt intake on sympathetic nerve activity (SNA) and CV function in salt-resistant humans as well as the underlying mechanisms contributing to these adverse effects. The long-term goal is to determine how dietary salt adversely affects BP regulation and CV health. The objective of this proposal is to comprehensively evaluate the impact of dietary salt intake on SNA and CV reactivity and BPV in normotensive humans. The investigators have 2 specific aims: 1) Aim 1 will test the hypothesis that high dietary salt increases SNA and CV reactivity in normotensive adults, 2) Aim 2 will test the hypothesis that high dietary salt increases BPV in normotensive adults. The expected outcome is to demonstrate that dietary salt loading increases CV reactivity and BPV through a sympathetic nervous system mechanism that originates in the brain. The proposed research is significant, as these studies will provide empirical evidence that dietary salt intake impacts neurohumoral control of the circulation in salt-resistant humans. The proposed research is innovative because it will identify a novel neurogenic action of dietary salt in human CV regulation.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Ten days of low sodium diet
Ten days of a medium sodium diet
Ten days of a high sodium diet
Time frame: Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)
Standard deviation of systolic blood pressure over 24 hours (mmHg)
Time frame: Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)
Change in Blood pressure during handgrip exercise (mmHg)
Time frame: Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)
Change in Blood pressure during a cold pressor test (mmHg)
Time frame: Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)
Sympathetic outflow (bursts per minute)
Time frame: Day 10 of diet (i.e., after 10 days of low, medium, and high sodium diets; crossover design)
Sympathetic outflow (bursts per minute)
University of Delaware
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04817137
Blood Pressure
Boston, Massachusetts, United States
View Trial DetailsNCT07713576
Blood Pressure
Chenzhou, Hunan, China
View Trial DetailsNCT06550297
Blood Pressure, Cardiovascular Diseases
New York, United States
View Trial DetailsNCT07317648
Blood Pressure
York, England, United Kingdom
View Trial Details